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Hepatocyte growth factor (HGF), a protein with pleiotropic biological activity affecting cell growth and motility, was found to markedly activate 
prostaglandin production in human gastric carcinoma TMK-1 cells. HPLC analysis revealed that HGF stimulated the production of prostaglandin 
E, (PGE,), which is the major prostaglandin produced in these cells. HGF maximally stimulated PGE2 production at a concentration of 10 @ml, 
and it was a more potent stimulator of PGE2 production than epidermal growth factor (EGF), which is known to stimulate prostaglandin production 
in various cell lines. The simultaneous addition of HGF and EGF caused no further stimulation of the PGE, production observed in HGF-treated 
cells. We showed also that HGF increased the arachidonate release from TMK-1 cells, which release was completely suppressed by the addition 
of phospholipase A, (PLA3 inhibitors. Further studies in vitro showed that HGF enhanced cellular activities of cytosolic PLA, and cyclooxygenase 
1 S-fold each. These results indicate that HGF stimulates prostaglandin production through increases in both cytosolic PLAz and cyclooxygenase 
activities. 
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1. INTRODUCTION 
Hepatocyte growth factor (HGF) was originally iden- 
tified as a potent mitogen of rat hepatocytes in primary 
culture [l-3]. HGF was also shown to stimulate the 
growth of many kinds of cells including melanocytes 
and endothelial cells as well as a variety of epithelial 
cells [4], but it was cytotoxic to a variety of tumor cell 
lines [5]. Recently, Widner et al. [6] reported that HGF 
is identical to ‘scatter factor’, which induces the disrup- 
tion and scattering of epithelial colonies and increases 
the movement of individual cells. Therefore, HGF in- 
duces different growth responses in different cells and 
is now recognized as a protein with pleiotropic biologi- 
cal activity affecting cell growth and motility. 
The HGF receptor is the c-met proto-oncogene prod- 
uct, which is rapidly tyrosine phosphorylated in re- 
sponse to HGF [7-81. Recently, it was suggested that 
several intracellular molecules are involved in the sig- 
naling of HGF. For example, the addition of HGF 
to rat hepatocytes induced the formation of l,Zdia- 
cylglycerol (DG) via phosphatidylcholine-phospholip- 
ase C (PLC) [9]. Furthermore, polyphosphoinositides 
generated by phosphatidylinositol 3-kinase are sug- 
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gested to be included in the signaling pathway of HGF 
[lo]. However, details of the signaling pathway follow- 
ing activation of the HGF receptor still remain to be 
elucidated. 
In this study, we examined whether HGF has an 
activity to stimulate the production of prostaglandins, 
which have been shown in various studies to play regu- 
latory roles in cell growth and other physiological re- 
sponses. We found that in TMK-1, a cell line derived 
from a human gastric carcinoma [l 11, HGF stimulated 
PGE, production through increases in both cytosolic 
phospholipase A, and cyclooxygenase activity. In addi- 
tion, HGF was a more effective stimulator than epider- 
ma1 growth factor, which is known to be a potent stim- 
ulator of prostaglandin production in various cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Recombinant human HGF produced in Chinese hamster ovary cells 
was provided by the Research Center, Mitsubishi Kasei Co. 
(Yokohama, Japan) [12]. EGF (ultrapure) from mouse submaxillary 
glands was purchased from Toyobo Co., Ltd. (Osaka, Japan); fetal 
calf serum (FCS), from Gibco Life Technologies, Inc. (Grand Island, 
NY); and RPMIl640, from Nissui Pharmaceutical Co., Ltd. (Tokyo, 
Japan). Prostaglandins were obtained from Sigma Co. (St. Louis, 
MO). All other reagents were of analytical grade. 
2.2. Cell cultures 
TMK-1 (poorly differentiated adenocarcinoma) isolated from 
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human gastric carcinoma [1 1] was kindly supplied by Dr. E. Tahara 
of Hiroshima University School of Medicine. The cells (2 x 10’) were 
plated on 35mm plastic dishes in 2 ml of RPM11640 supplemented 
with 5% FCS and 10 pg/ml gentamicin (Sigma) and used for all 
experiments after 2 days in culture. 
2.3. Assays of prostaglandin production 
Growing TMK-1 cells were incubated with various concentrations 
of HGF in fresh medium supplemented with 5% FCS. Prostaglandins 
were extracted from the culture medium by the use of a Sep-Pak C-18 
cartridge (Waters; Milford, MA) and were analyzed by HPLC or with 
a [“‘I]PGE, radioimmunoassay (RIA) kit (New England Nuclear; 
Boston, MA) as described previously [13]. 
2.4. Release of [-‘H]arachidonate 
Growing TMK-1 cells were prelabeled with 0.5 &i/ml [3H]ara- 
chidonic acid (95.1 Ci/ml; NEN) for 24 h. Then the cells were treated 
with either HGF or EGF in fresh medium. At specified times, the 
radioactivity released into the medium was measured as described 
previously [14]. 
2.5 Assay of phospholipase A, activity 
Growing TMK-1 cells were incubated with or without 10 ng/ml 
HGF for 4 h. The PLA, activitities in TMK-1 cytosol were measured 
as previously described [15]. 
2.6. Assay of cyclooxygenase activity 
The solubilized TMK-1 somcate was prepared as described by Raz 
et al. [16], and assayed for cyclooxygenase activity by measuring con- 
version of the added arachidonic acid to prostaglandin E,. The assay 
mixture contained the following in a total volume of 100 ~1: 50 mM 
Tris (pH 8.0) 5 mM tryptophan, 5 mM reduced glutathione, 2 PM 
hematm, and solubilized cell sonicate (100 pug of protein). The mixture 
was preincubated for 2 min at 37°C and the assay was started by the 
addition of 100 PM arachidonic acid in ethanol. After incubation for 
2 min at 37”C, the reaction was stopped by the addition of ice-cold 
ethanol. Produced prostaglandins were extracted and measured by 
RIA. 
3. RESULTS AND DISCUSSION 
Prostaglandin production of TMK-1 cells was ana- 
lyzed by reverse-phase HPLC. PGE, was detected as the 
major prostaglandin in both the control and the HGF- 
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Fig. 1. HPLC analysis of [‘4C]arachidonic acid metabolites. TMK-1 
cells were prelabeled with [‘4C]arachidonic a id (1 @/ml) for 24 h and 
further incubated with or without 10 @ml HGF for 4 h. The super- 
natants were collected and analyzed by HPLC. Prostaglandins were 
identified by comparison of their retention times with those of authen- 
tic standards. 
Fig. 2. Dose-response and time course of PGEl production by HGF. 
(A) TMK-1 cells were incubated with indicated concentrations of 
HGF for 4 h. (B) TMK-1 cells were incubated with (0) or without (a) 
10 @ml HGF for the indicated times. PGE, levels in the culture 
medium were determined by RIA. Values are means + S.D. for trip- 
licate cultures. Similar results were obtained in two independent exper- 
iments. 
treated cultures, and its amount was increased by HGF 
treatment (Fig. 1). The increase in PGE, production was 
confirmed by radioimmunoassay of PGE, (Fig. 2). 
HGF stimulated PGE2 production in a dose-dependent 
(Fig. 2A) and time-dependent (Fig. 2B) manner. The 
maximal effect of HGF was obtained at a concentration 
of 10 ng/ml and after a 6-h treatment. 
We next compared the activity of HGF to stimulate 
prostaglandin production with that of EGF, whose re- 
ceptor protein is also known to be a transmembrane 
protein with tyrosine kinase activity. HGF (10 r&ml) 
increased the amount of PGEz about 4-fold; whereas 
EGF (10 ng/ml) increased it about 2-fold (Fig. 3) indi- 
cating HGF to be a more potent stimulator of PGE, 
production than EGF. The figure also indicates that 
treatment of cells with EGF in combination with HGF 
did not cause any further increase in PGE, production 
by HGF-treated cells. 
Prostaglandin production is regulated at either or 
both of two key enzymatic steps. The first step is the 
release of arachidonic acid from cellular phospholipids 
by phospholipase; and the second, conversion of re- 
leased arachidonate into prostaglandins by cyclooxyge- 
nase (PGH synthase). So we first determined the effect 
of HGF and EGF on arachidonate release from TMK- 1 
cells. As shown in Fig. 4, both HGF and EGF increased 
the release in a time-dependent manner for up to 2 h of 
incubation, and HGF was a more potent stimulator of 
arachidonate release than EGF. Combined treatment of 
cells with HGF and EGF did not augment he release 
over that seen from cells treated with HGF alone. The 
potency of HGF and EGF for arachidonate release was 
closely related to that for PGE, production; thus the 
increase in PGE, level is thought to reflect the stimula- 
tion of arachidonate release. The release of arachidonic 
acid from the m-2 position of membrane phospholipids 
has been ascribed either to activity of phospholipase A, 
(PLA,) or to the sequential action of phospholipase C 
(PLC) and DG lipase. Recently it was reported that 
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Fig. 3. Stimulation of prostaglandin E2 production by HGF and EGF. 
TMK-1 cells were incubated with 10 ng/ml HGF, 10 tug/ml EGF, or 
their combination for 4 h. PGE, levels in the culture medium were 
determined by RIA. Values are means f. SD. for triplicate cultures. 
Similar results were obtained in two independent experiments. Signif- 
icance of difference was determined by Student’s r-test. **P < 0.01, 
***P < 0.001 vs. control. 
HGF stimulated the formation of 1,2-diacylglycerol- 
(1,2-DG) by PLC, and that the peak of DG formation 
was observed at 5 min after stimulation [9]. However, 
in this study the arachidonate release increased up to 2 
h after HGF-treatment. This prolonged stimulation 
may be mediated by PLA, rather than PLC. Therefore, 
we examined effect of PLA, inhibitors on the ara- 
chidonate release. As shown in the inset of Fig. 4, either 
p-bromophenacylbromide (p-BPB) or quinacrine (QC) 
at a concentration of 30 ,uM completely inhibited HGF- 
induced arachidonate release to the control level, 
whereas neither reagent had a significant effect on ara- 
chidonate release from control cultures. These results 
support our consideration that PLA, is involved in the 
stimulation of arachidonate release in TMK-1 cells. 
Furthermore, we measured the enzymatic activity of 
PLA, in vitro. The Ca*’ requirement of PLA, was ex- 
amined at pH 7.4 with Ca*‘/EDTA buffers [17]. No 
appreciable activity was detected in the presence of 
EDTA, while significant activity was observed at micro- 
molar concentrations of free Ca” (data not shown). 
HGF caused a 1.5fold increase in PLA, activity at lo-’ 
M free Ca2’ (Table I); however, the factor caused no 
further enhancement of PLA, activity even at millimo- 
lar concentrations of Ca*‘. Next we characterized the 
substrate specificity of PLA,. As shown in Table I, 
TMK- 1 PLA, hydrolyzed l-palmitoyl-2-[‘4C]ara- 
chidonoyl-sn-glycero-3-phosphocholine 1Cfold more 
effectively than that it hydrolyzed l-palmitoyl-2-[14C]1i- 
noleoyl-sn-glycero-3-phosphocholine. These enzymol- 
ogical data indicate that the stimulation by HGF caused 
the enhancement of cytosolic PLA, activity in TMK-1 
cells. 
Since Lin et al. recently reported the phosphoryla- 
tion and activation of cytosolic PLA, by mitogen-acti- 
vated protein (MAP) kinase [ 181, it will be interesting in 
Table I 
Cytosolic phospholipase A, activity of TMK-1 cells stimulated by 
HGF 
Substrate PLA, activity 
(pmol/min/mg protein) 
Control HGF 
2-Arachidonoyl-PC 
2-Linoleoyl-PC 
142 f 16 212 * 13*** 
lo? 2 16f 2*** 
TMK-1 cells were incubated with or without 10 ng/ml HGF for 4 h. 
PLA, activities in TMK-1 cytosol were assayed with I-palmitoyl-2- 
[‘4C]arachidonoyl-sn-glycero-3-phosphocholine (2-Arachidonoyl-PC) 
or l-palmitoyl-2-[‘4C]linoleoyl-sn-glycero-3-phosphocholine (2-Lino- 
leoyl-PC) as described previously [151. Values are the means f SD. of 
ten determinations. Similar results were obtained in two independent 
experiments. Significance of difference was determined by Student’s 
t-test. 
***P < 0.001 vs. control. 
future studies to elucidate whether MAP kinase plays 
a role in the signal transduction from HGF and EGF 
receptors to PLA,. 
Next, we measured the activity of cyclooxygenase in 
TMK-1 cells that had been preincubated with either 
HGF or EGF. Solubilized fractions prepared from 
these cells were incubated with arachidonic acid, and 
the PGE2 produced was measured by the radioimmu- 
noassay for PGE2. HGF caused about a 1.5-fold in- 
crease in PGE2 production over the level in control cells, 
whereas EGF did not enhance cyclooxygenase activity 
(Table II). The combination of HGF and EGF also 
HGF+EGF 
J 
0 1.0 2.0 3.0 4.0 
Time (h) 
Fig. 4. Arachidonate release stimulated by HGF and EGF. Ara- 
chidonate release was determined at various times after the addition 
of the growth factors. TMK-1 cells prelabeled with [‘Hlarachidonic 
acid (0.5 pCi/ml) were incubated in 5% FCS/RPMI containing 10 
rig/ml HGF (o), 10 ng/ml EGF (a), combination of HGF and EGF 
(r), or no growth factor (0). Amount of the released [‘warachidonate 
was expressed as a percentage of total counts incorporated into the 
cells. Inset: the effect of PLA, inhibitors on the arachidonate release. 
The cells were incubated with PLA, inhibitors, p-bromophenacylbro- 
mide@BPB; 0, l ) or quinacrine (QC; a, A), in the presence (closed 
symbols) or absence (open symbols) of 10 rig/ml HGF. Released ara- 
chidonate after a 2-h incubation is indicated as a percentage. Values 
are means for triplicate cultures. Similar results were obtained in two 
independent experiments. 
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